NCT06632158 (PRoP-AA) is a Phase 2 clinical trial of MindBoba in Behavior, sponsored by IRIS Media Inc.

Who is sponsoring NCT06632158?

NCT06632158 is sponsored by IRIS Media Inc.

What drugs are being tested in NCT06632158?

Interventions in NCT06632158: MindBoba, Mindshift CBT.

What condition does NCT06632158 study?

NCT06632158 studies Behavior, Stress, Anxiety.

Is NCT06632158 still recruiting?

NCT06632158 is currently completed. Last updated 1 May 2025.

Last reviewed 2025-05-01 · How we verify

NCT06632158: PRoP-AA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Personal Relevance of Psychotherapy for Asian Americans

Completed Phase 2 Last updated 1 May 2025

What this trial tests

Phase 2 trial testing MindBoba in Behavior in 268 participants. Completed in 30 December 2024.

Timeline

1 May 2024

Primary endpoint
30 December 2024

30 December 2024

Quick facts

Lead sponsor	IRIS Media Inc
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	268
Start date	1 May 2024
Primary completion	30 December 2024
Estimated completion	30 December 2024
Sites	1 location across United States

Drugs / interventions tested

MindBoba
Mindshift CBT

Conditions studied

Behavior — all drugs for Behavior →
Stress — all drugs for Stress →
Anxiety — all drugs for Anxiety →

Sponsor

IRIS Media Inc

Who can join

18 and older, any sex, with Behavior or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using a three-armed design the investigators will test whether participants in the Mindboba online application experience significantly greater improvements as compared to participants in the active control (online app based on Cognitive Behavioral Therapy) and participants in the business-as-usual control. The outcome measures are self-reported social problem-solving, self-efficacy, stress, depression, anxiety, attitudes towards seeking mental health, and knowledge.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Behavior

Currently open trials in the same condition.

NCT07373626 — Physical Activity Trends in Cancer Survivors Treated at the 'MOvement and REhabilitation' Clinic · recruiting
NCT06908447 — Cold Water and Decision-Making · NA · recruiting
NCT07133529 — Decision-making and Food Intake · NA · recruiting
NCT06862193 — Effectiveness of Digital Intervention (HM4MH-app) on Perinatal Psychological Wellbeing · NA · recruiting
NCT06593613 — Pilot Trial of the RUBI Program for Autistic Adults · NA · recruiting

Other IRIS Media Inc trials

Trials by the same sponsor.

NCT06809153 — Putting Children First - Parent Training for Parents in High Conflict · Phase 2 · not yet recruiting
NCT04000841 — Culturally Responsive Stress Reduction: A Mobile Mindfulness Application for African Americans (CRSR) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06632158 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRIS Media Inc
Last refreshed: 1 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06632158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing